TBVAC-HORIZON: Innovating and diversifying the TB vaccine pipeline


TBVAC-HORIZON receives funding from the European Union’s Horizon Europe research and innovation programme under grant agreement No 101080309. It is funded by the European Union, the UK Research and Innovation, and the Swiss State Secretariat for Education, Research and Innovation. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union, UKRI, SERI nor the granting authority can be held responsible for them.